Artículos galardonado con el Premio al Mejor Artículo Científico de 2021 publicado en la revista oficial de la Health Technology Assessment international (HTAi).The Monitoring Studies (MS) program, the approach developed by RedETS to generate postlaunch real-world evidence (RWE), is intended to complement and enhance the conventional health technology assessment process to support health policy decision making in Spain, besides informing other interested stakeholders, including clinicians and patients. The MS program is focused on specific uncertainties about the real effect, safety, costs, and routine use of new and insufficiently assessed relevant medical devices carefully selected to ensure the value of the additional research needed, b...
OBJECTIVE: There is no health system that has the resources to evaluate all technologies. The presen...
To compare the use of health technology assessment (HTA) as a tool to support pricing and reimbursem...
Experiences with coverage with evidence development (CED) schemes are fairly limited in Central and ...
The Monitoring Studies (MS) program, the approach developed by RedETS to generate postlaunch real-wo...
The Monitoring Studies (MS) program, the approach developed by RedETS to generate postlaunch real-wo...
Noticia publicada en la web del ISCIII el 08/07/2022.Un artículo en el que participan investigadores...
Objectives: A centralised approach to health technology assessment (HTA) may facilitate optimal use ...
Objective: To compare the use of health technology assessment (HTA) as a tool to support pricing and...
Availability of data and materials: Not applicable for this opinion paper.Copyriight © The Author(s)...
This article identifies the main challenges of the National Health Service of Spain and proposes its...
Funding Information: This study was supported by the European Union Horizon 2020 Research and Innova...
Health technology assessment (HTA) is increasingly informed by nonrandomized studies, but there is l...
Funding Information: MEA and MIP. These methods might be a relevant mechanism to improve access. How...
The establishment of health technology assessment (HTA) has been an important topic in Europe for ma...
This article presents the ex-post assessment of a program of clinical and health services research a...
OBJECTIVE: There is no health system that has the resources to evaluate all technologies. The presen...
To compare the use of health technology assessment (HTA) as a tool to support pricing and reimbursem...
Experiences with coverage with evidence development (CED) schemes are fairly limited in Central and ...
The Monitoring Studies (MS) program, the approach developed by RedETS to generate postlaunch real-wo...
The Monitoring Studies (MS) program, the approach developed by RedETS to generate postlaunch real-wo...
Noticia publicada en la web del ISCIII el 08/07/2022.Un artículo en el que participan investigadores...
Objectives: A centralised approach to health technology assessment (HTA) may facilitate optimal use ...
Objective: To compare the use of health technology assessment (HTA) as a tool to support pricing and...
Availability of data and materials: Not applicable for this opinion paper.Copyriight © The Author(s)...
This article identifies the main challenges of the National Health Service of Spain and proposes its...
Funding Information: This study was supported by the European Union Horizon 2020 Research and Innova...
Health technology assessment (HTA) is increasingly informed by nonrandomized studies, but there is l...
Funding Information: MEA and MIP. These methods might be a relevant mechanism to improve access. How...
The establishment of health technology assessment (HTA) has been an important topic in Europe for ma...
This article presents the ex-post assessment of a program of clinical and health services research a...
OBJECTIVE: There is no health system that has the resources to evaluate all technologies. The presen...
To compare the use of health technology assessment (HTA) as a tool to support pricing and reimbursem...
Experiences with coverage with evidence development (CED) schemes are fairly limited in Central and ...